Prostate specific antigen production by breast tumors after induction with oral contraceptives.
Katsaros
D
D
Department of Gynecologic Oncology, University of Turin, Italy.
Melegos
D N
DN
Diamandis
E P
EP
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000097:blood / Q000378:metabolism*; D018270:Carcinoma, Ductal, Breast / Q000097:blood / Q000378:metabolism; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage*; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D011372:Progestins / Q000008:administration & dosage; D017430:Prostate-Specific Antigen / Q000096:biosynthesis* / Q000097:blood / Q000187:drug effects; D011960:Receptors, Estrogen / Q000032:analysis / Q000097:blood; D011980:Receptors, Progesterone / Q000032:analysis / Q000097:blood
D003280:Contraceptives, Oral, Synthetic; D011372:Progestins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D004997:Ethinyl Estradiol; D017430:Prostate-Specific Antigen